Key facts
- Jacob Safier filed SCHEDULE 13G/A for T2 Biosystems, Inc. Common Stock, par value $0.001 per share (TTOO).
- Disclosed ownership: 5.3%.
- Date of event: 31 Dec 2024.
Jacob Safier - 31 Dec 2024 SCHEDULE 13G/A Report for T2 Biosystems, Inc. Common Stock, par value $0.001 per share (TTOO)
- Filing Manager
- Jacob Safier
- Reporting Manager
- Safier Jacob
- Symbol
- TTOO
- Shares outstanding
- 28,301,887 shares
- Disclosed Ownership
- 1,500,000 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2025, 21:22:11 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Key filing fact
Jacob Safier disclosed 5.3% ownership in T2 Biosystems, Inc. Common Stock, par value $0.001 per share (TTOO) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 21:22.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Safier Jacob | 5.3% | 1,500,000 | 1,500,000 | 0 | /s/ Jacob Safier | Jacob Safier | |
| JSAF Holdings, LLC | 5.3% | 1,500,000 | 1,500,000 | 0 | /s/ Jacob Safier | Jacob Safier, Manager |
CIK / CUSIP context first